Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Medifast (MED) Other financing activities (2016 - 2021)

Medifast's Other financing activities history spans 12 years, with the latest figure at $34000.0 for Q3 2021.

For Q3 2021, Other financing activities fell 5.56% year-over-year to $34000.0; the TTM value through Sep 2021 reached $1.9 million, up 233.81%, while the annual FY2020 figure was $551000.0, 96.09% down from the prior year.
Other financing activities reached $34000.0 in Q3 2021 per MED's latest filing, up from $26000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $2.2 million in Q4 2017 to a low of $9000.0 in Q2 2020.
Average Other financing activities over 5 years is $372937.5, with a median of $35000.0 recorded in 2018.
Peak YoY movement for Other financing activities: tumbled 78.46% in 2018, then surged 271.05% in 2021.
A 5-year view of Other financing activities shows it stood at $2.2 million in 2017, then crashed by 78.46% to $471000.0 in 2018, then tumbled by 92.99% to $33000.0 in 2019, then crashed by 42.42% to $19000.0 in 2020, then skyrocketed by 78.95% to $34000.0 in 2021.
Per Business Quant, the three most recent readings for MED's Other financing activities are $34000.0 (Q3 2021), $26000.0 (Q2 2021), and $1.8 million (Q1 2021).